JP2016130237A - 水不溶性スポンジに紫外線遮断機能を有する化粧料組成物が含浸された化粧品 - Google Patents
水不溶性スポンジに紫外線遮断機能を有する化粧料組成物が含浸された化粧品 Download PDFInfo
- Publication number
- JP2016130237A JP2016130237A JP2016000849A JP2016000849A JP2016130237A JP 2016130237 A JP2016130237 A JP 2016130237A JP 2016000849 A JP2016000849 A JP 2016000849A JP 2016000849 A JP2016000849 A JP 2016000849A JP 2016130237 A JP2016130237 A JP 2016130237A
- Authority
- JP
- Japan
- Prior art keywords
- water
- cosmetic composition
- cosmetic
- blocking agent
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 153
- 239000000203 mixture Substances 0.000 title claims abstract description 124
- 230000000903 blocking effect Effects 0.000 title abstract description 49
- 239000002981 blocking agent Substances 0.000 claims abstract description 89
- 239000012071 phase Substances 0.000 claims description 53
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 229920000459 Nitrile rubber Polymers 0.000 claims description 17
- 239000008346 aqueous phase Substances 0.000 claims description 17
- 239000005062 Polybutadiene Substances 0.000 claims description 11
- 229920002857 polybutadiene Polymers 0.000 claims description 11
- 229920003048 styrene butadiene rubber Polymers 0.000 claims description 10
- 244000043261 Hevea brasiliensis Species 0.000 claims description 8
- 229920003052 natural elastomer Polymers 0.000 claims description 8
- 229920001194 natural rubber Polymers 0.000 claims description 8
- 239000000839 emulsion Substances 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 6
- 230000002209 hydrophobic effect Effects 0.000 claims description 4
- 239000000178 monomer Substances 0.000 claims description 4
- 239000007764 o/w emulsion Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 abstract description 9
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 18
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 9
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 9
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 9
- 229960001679 octinoxate Drugs 0.000 description 9
- 206010015150 Erythema Diseases 0.000 description 8
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 8
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 8
- 231100000321 erythema Toxicity 0.000 description 8
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 229960000655 ensulizole Drugs 0.000 description 7
- -1 polyethylene Polymers 0.000 description 7
- 238000001179 sorption measurement Methods 0.000 description 7
- 239000004698 Polyethylene Substances 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 229920000573 polyethylene Polymers 0.000 description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 description 5
- 239000004814 polyurethane Substances 0.000 description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000002174 Styrene-butadiene Substances 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000005470 impregnation Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 description 3
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 101100351735 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ptr-4 gene Proteins 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 101150070307 PFA4 gene Proteins 0.000 description 2
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 2
- 208000000453 Skin Neoplasms Diseases 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- 229960001173 oxybenzone Drugs 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 201000000849 skin cancer Diseases 0.000 description 2
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- 101000642333 Homo sapiens Survival of motor neuron-related-splicing factor 30 Proteins 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 102100036412 Survival of motor neuron-related-splicing factor 30 Human genes 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- OSPYXUDVXSLVLJ-UHFFFAOYSA-N calcium cerium(3+) oxygen(2-) Chemical compound [Ca+2].[O-2].[Ce+3] OSPYXUDVXSLVLJ-UHFFFAOYSA-N 0.000 description 1
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 1
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 1
- GLCJMPWWQKKJQZ-UHFFFAOYSA-L disodium;2-[4-(4,6-disulfonato-1h-benzimidazol-2-yl)phenyl]-1h-benzimidazole-4,6-disulfonate;hydron Chemical compound [Na+].[Na+].C1=C(S(O)(=O)=O)C=C2NC(C3=CC=C(C=C3)C3=NC4=C(C=C(C=C4N3)S(=O)(=O)O)S([O-])(=O)=O)=NC2=C1S([O-])(=O)=O GLCJMPWWQKKJQZ-UHFFFAOYSA-L 0.000 description 1
- 229960000979 drometrizole Drugs 0.000 description 1
- HEAHZSUCFKFERC-UHFFFAOYSA-N ecamsule Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2=CC(C=C1)=CC=C1C=C1C(=O)C2(CS(O)(=O)=O)CCC1C2(C)C HEAHZSUCFKFERC-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229960004697 enzacamene Drugs 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003061 melanogenesis Effects 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- 239000004533 oil dispersion Substances 0.000 description 1
- 239000008385 outer phase Substances 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 229940100498 polysilicone-15 Drugs 0.000 description 1
- 229920002282 polysilicones-15 Polymers 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 229960000368 sulisobenzone Drugs 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
I.水溶性または水分散性有機紫外線遮断剤;
II.水不溶性から水溶性または水分散性に転換された有機紫外線遮断剤;若しくは
III.カプセル化された有機紫外線遮断剤。
I.水溶性または水分散性有機紫外線遮断剤;
II.水不溶性から水溶性または水分散性に転換された有機紫外線遮断剤;若しくは
III.カプセル化された有機紫外線遮断剤、
油溶性有機紫外線遮断剤を化粧料組成物に含まれる有機紫外線遮断剤総重量の10%未満で含むことを特徴とする化粧品を提供する。
本発明による化粧料組成物は紫外線遮断剤を含む。
I.水溶性または水分散性有機紫外線遮断剤;
II.水不溶性から水溶性または水分散性に転換された有機紫外線遮断剤;若しくは
III.カプセル化された有機紫外線遮断剤、
油溶性有機紫外線遮断剤を化粧料組成物に含まれる有機紫外線遮断剤総重量の50%未満、40%未満、30%未満、20%未満、10%未満、9重量%未満、8重量%未満、7重量%未満、6重量%未満、5重量%未満、4重量%未満、3重量%未満、2重量%未満、1重量%未満、0.5重量%未満、0.05重量%未満、0.0005重量%未満、または最も望ましくは0.00001重量%未満で含むことができる。
本発明による水不溶性スポンジは、化粧料組成物含浸用として当業界で通常用いられるものであれば制限なく使用でき、例えばスチレンブタジエンゴム(SBR)、ブタジエンゴム(BR)、天然ゴム(NR)、アクリロニトリルブタジエンゴム(NBR)、アクリロニトリル‐ブタジエンスチレン(ABS)、ポリエチレン(PE)、ポリビニルアルコール(PVA)、エチレンビニルアルコール(EVA)、ポリウレタン(PU)などの高分子を発泡加工したものであり得る。
本発明は、水不溶性スポンジと、前記水不溶性スポンジに含浸させる化粧料組成物とを含む化粧品を提供する。
I.水溶性または水分散性有機紫外線遮断剤;
II.水不溶性から水溶性または水分散性に転換された有機紫外線遮断剤;若しくは
III.カプセル化された有機紫外線遮断剤、
油溶性有機紫外線遮断剤を化粧料組成物に含まれる有機紫外線遮断剤総重量の50%未満、40%未満、30%未満、20%未満、10%未満、9重量%未満、8重量%未満、7重量%未満、6重量%未満、5重量%未満、4重量%未満、3重量%未満、2重量%未満、1重量%未満、0.5重量%未満、0.05重量%未満、0.0005重量%未満、または最も望ましく0.00001重量%未満で含むことができる。
下記表1に記載された成分及び含量で油中水型ファンデーションを製造した。
比較例1では、油溶性有機紫外線遮断剤(エチルヘキシルメトキシシンナメート(EHMC)、イソアミルP‐メトキシシンナメート(IAMC)、エチルヘキシルサリチレート(EHS))及び無機紫外線遮断剤(二酸化チタン)を含む油中水型ファンデーションを製造した。一方、実施例1及び実施例2では、水溶性有機紫外線遮断剤(フェニルベンズイミダゾールスルホン酸(PBSA))及び無機紫外線遮断剤(二酸化チタン)を含む油中水型ファンデーションを製造した。
油相槽に油相成分と増粘剤を入れ、80℃に熱を加えて均一にした後、顔料を入れて分散させた。水相槽には水相成分を入れ、80℃に熱を加えて原料を完全に溶解させた後、顔料が分散している油相槽に添加してホモミキサーで乳化し、低粘度紫外線遮断油化物を製造した。40mlの安定性容器に内容物を充填し、25℃のチャンバに1日以上保管した後、ブルックフィールドLVII粘度計にスピンドル4番を用いて30rpmで1分間作動させた後、25℃で粘度を測定した結果4,000cpsであった。
比較例1−2と実施例1−2のファンデーションをそれぞれSBR、NBR、そしてPUに15gずつ含浸させた後、25℃のチャンバで1日以上保管した。スポンジの表面から含浸されていないファンデーションを除去した後、以下のように試験を行った。
フェニルベンズイミダゾールスルホン酸の量(mg)=AT/As×フェニルベンズイミダゾールスルホン酸標準品の量(mg)
エチルヘキシルサリチレートの量(mg)=AT/As×エチルヘキシルサリチレート標準品の量(mg)
イソアミルP‐メトキシシンナメートの量(mg)=AT/As×イソアミルP‐メトキシシンナメート標準品の量(mg)
その結果は表2(比較例1)、表3(実施例1)のようであった。
その結果は表4(比較例1−2と実施例1−2に対するin−vitro SPF、in−vitro PFA数値)のようである。
Claims (5)
- 水不溶性スポンジと、前記水不溶性スポンジに含浸させる化粧料組成物とを含む化粧品において、
前記化粧料組成物は、以下のいずれか1つ以上の有機紫外線遮断剤を含み、
(i)水溶性または水分散性有機紫外線遮断剤;
(ii)水不溶性から水分散性に転換された有機紫外線遮断剤;若しくは
(iii)カプセル化された有機紫外線遮断剤、
油溶性有機紫外線遮断剤を化粧料組成物に含まれる有機紫外線遮断剤総重量の10%未満で含むことを特徴とする化粧品。 - 前記化粧料組成物は、無機紫外線遮断剤をさらに含むことを特徴とする請求項1に記載の化粧品。
- 前記化粧料組成物の剤形は、水相単独、水中油型エマルション、または化粧料組成物の最外相が水相である多重エマルションであることを特徴とする請求項1に記載の化粧品。
- 前記水不溶性スポンジは、スチレンブタジエンゴム(SBR)、ブタジエンゴム(BR)、天然ゴム(NR)またはアクリロニトリルブタジエンゴム(NBR)が含まれる疎水性単量体高分子で形成されたことを特徴とする請求項1に記載の化粧品。
- 前記化粧料組成物は、ファンデーションであることを特徴とする請求項1に記載の化粧品。
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150004142A KR101542917B1 (ko) | 2015-01-12 | 2015-01-12 | 수불용성 스폰지에 자외선 차단기능을 지닌 화장료 조성물이 함침된 화장품 |
KR10-2015-0004142 | 2015-01-12 | ||
KR10-2015-0013647 | 2015-01-28 | ||
KR20150013647 | 2015-01-28 | ||
KR1020150109816A KR20160092899A (ko) | 2015-01-28 | 2015-08-04 | 수불용성 스폰지에 자외선 차단기능을 지닌 화장료 조성물이 함침된 화장품 |
KR10-2015-0109816 | 2015-08-04 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017036134A Division JP6742258B2 (ja) | 2015-01-12 | 2017-02-28 | 水不溶性スポンジに紫外線遮断機能を有する化粧料組成物が含浸された化粧品 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016130237A true JP2016130237A (ja) | 2016-07-21 |
JP6113871B2 JP6113871B2 (ja) | 2017-04-12 |
Family
ID=56405992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016000849A Active JP6113871B2 (ja) | 2015-01-12 | 2016-01-06 | 水不溶性スポンジに紫外線遮断機能を有する化粧料組成物が含浸された化粧品 |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP6113871B2 (ja) |
MY (1) | MY182398A (ja) |
WO (1) | WO2016114466A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018016931A1 (ko) * | 2016-07-22 | 2018-01-25 | 코스맥스 주식회사 | 특정 고무를 이용한 화장료 수용체를 포함하는 화장품 |
JP2018089384A (ja) * | 2012-04-12 | 2018-06-14 | アモーレパシフィック コーポレーション | 担体発泡フォームと化粧料組成物とを有する化粧品 |
WO2018159651A1 (ja) * | 2017-03-03 | 2018-09-07 | 株式会社資生堂 | 化粧品 |
JP2019131489A (ja) * | 2018-01-30 | 2019-08-08 | 株式会社 資生堂 | 含浸用油中水型乳化化粧料 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02231463A (ja) * | 1988-11-22 | 1990-09-13 | L'oreal Sa | ベンジリデン―カンファースルホン化誘導体および紫外線防止剤 |
JPH07101847A (ja) * | 1993-09-30 | 1995-04-18 | Shiseido Co Ltd | 乳化組成物 |
JP2002284638A (ja) * | 2001-03-28 | 2002-10-03 | Kose Corp | 水中油型乳化化粧料 |
JP2006008691A (ja) * | 2004-06-28 | 2006-01-12 | L'oreal Sa | 親水性スクリーニング剤を含む水中油型ファインエマルション |
JP2013053073A (ja) * | 2011-08-31 | 2013-03-21 | Kose Corp | 化粧料 |
WO2013154391A1 (ko) * | 2012-04-13 | 2013-10-17 | (주)아모레퍼시픽 | 발포 폼을 포함하는 화장료 조성물 담체 |
WO2013154392A1 (ko) * | 2012-04-12 | 2013-10-17 | (주)아모레퍼시픽 | 개선된 사용감을 가지는 발포 폼 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2881650B1 (fr) * | 2005-02-09 | 2008-12-26 | Oreal | Article cosmetique de demaquillage |
CN104379021B (zh) * | 2012-06-29 | 2018-10-02 | 株式会社爱茉莉太平洋 | 包括涂抹用海绵的化妆品容器 |
-
2015
- 2015-08-12 MY MYPI2017702531A patent/MY182398A/en unknown
- 2015-08-12 WO PCT/KR2015/008461 patent/WO2016114466A1/ko active Application Filing
-
2016
- 2016-01-06 JP JP2016000849A patent/JP6113871B2/ja active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02231463A (ja) * | 1988-11-22 | 1990-09-13 | L'oreal Sa | ベンジリデン―カンファースルホン化誘導体および紫外線防止剤 |
JPH07101847A (ja) * | 1993-09-30 | 1995-04-18 | Shiseido Co Ltd | 乳化組成物 |
JP2002284638A (ja) * | 2001-03-28 | 2002-10-03 | Kose Corp | 水中油型乳化化粧料 |
JP2006008691A (ja) * | 2004-06-28 | 2006-01-12 | L'oreal Sa | 親水性スクリーニング剤を含む水中油型ファインエマルション |
JP2013053073A (ja) * | 2011-08-31 | 2013-03-21 | Kose Corp | 化粧料 |
WO2013154392A1 (ko) * | 2012-04-12 | 2013-10-17 | (주)아모레퍼시픽 | 개선된 사용감을 가지는 발포 폼 |
WO2013154391A1 (ko) * | 2012-04-13 | 2013-10-17 | (주)아모레퍼시픽 | 발포 폼을 포함하는 화장료 조성물 담체 |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018089384A (ja) * | 2012-04-12 | 2018-06-14 | アモーレパシフィック コーポレーション | 担体発泡フォームと化粧料組成物とを有する化粧品 |
WO2018016931A1 (ko) * | 2016-07-22 | 2018-01-25 | 코스맥스 주식회사 | 특정 고무를 이용한 화장료 수용체를 포함하는 화장품 |
JP2019532020A (ja) * | 2016-07-22 | 2019-11-07 | コスマックス、インコーポレイテッド | 特定ゴムを用いた化粧料収容体を含む化粧品 |
WO2018159651A1 (ja) * | 2017-03-03 | 2018-09-07 | 株式会社資生堂 | 化粧品 |
JPWO2018159651A1 (ja) * | 2017-03-03 | 2019-12-26 | 株式会社 資生堂 | 化粧品 |
US11000463B2 (en) | 2017-03-03 | 2021-05-11 | Shiseido Company, Ltd. | Cosmetic including liquid cosmetic impregnated into impregnated body |
JP7219702B2 (ja) | 2017-03-03 | 2023-02-08 | 株式会社 資生堂 | 化粧品 |
JP2019131489A (ja) * | 2018-01-30 | 2019-08-08 | 株式会社 資生堂 | 含浸用油中水型乳化化粧料 |
JP7079610B2 (ja) | 2018-01-30 | 2022-06-02 | 株式会社 資生堂 | 含浸用油中水型乳化化粧料 |
Also Published As
Publication number | Publication date |
---|---|
JP6113871B2 (ja) | 2017-04-12 |
WO2016114466A1 (ko) | 2016-07-21 |
MY182398A (en) | 2021-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2718712C (en) | Cosmetic product comprising uv-blocking cosmetic composition impregnated into expanded urethane foam | |
JP6113871B2 (ja) | 水不溶性スポンジに紫外線遮断機能を有する化粧料組成物が含浸された化粧品 | |
KR102656734B1 (ko) | 썬스크린 조성물 | |
KR102092297B1 (ko) | 수불용성 스폰지에 자외선 차단기능을 지닌 화장료 조성물이 함침된 화장품 | |
KR102249023B1 (ko) | 유기 자외선 차단제를 이용한 투명한 스프레이형 자외선 차단용 화장료 조성물 | |
RU2690181C2 (ru) | Солнцезащитная композиция в порошкообразной форме | |
KR101455833B1 (ko) | 파우더상의 자외선 차단 화장료 조성물 | |
JP2017088631A (ja) | 水不溶性スポンジに紫外線遮断機能を有する化粧料組成物が含浸された化粧品 | |
KR101542917B1 (ko) | 수불용성 스폰지에 자외선 차단기능을 지닌 화장료 조성물이 함침된 화장품 | |
KR20060024612A (ko) | 자외선 차단 화장료 함침 시트 | |
KR101781571B1 (ko) | 자외선 차단용 화장료 조성물 | |
KR102587916B1 (ko) | 유기계 자외선 차단제를 포함하는 실리콘중수 타입의 화장료 조성물 | |
CN106332545A (zh) | 可喷涂的防晒组合物和方法 | |
TW201713302A (zh) | 包含具有紫外線阻斷功能的化妝料組合物的彈性網化妝品 | |
KR20170054238A (ko) | 내수성이 우수한 수중유형 자외선 차단용 화장료 조성물 | |
WO2007042346A1 (en) | Mixtures of ethylhexyl p-methoxycinnamate and ethylhexyl salicylate | |
RU2787145C2 (ru) | Распыляемая солнцезащитная композиция | |
KR20110104760A (ko) | 고기능성 천연 자외선 차단크림 조성물 | |
TW200924800A (en) | A long-acting, waterproof or water-resistant, topical sun protection agent with activity up to weeks | |
KR20160076408A (ko) | 발포 NBR(nitrile butadiene rubber) 폼에 함침시켜 제조하는 자외선 차단 화장료 조성물 | |
KR20230044049A (ko) | 아스타잔틴을 유효성분으로 하는 자외선 차단 조성물 | |
KR101289431B1 (ko) | 캠페리트린을 함유한 자외선 차단 화장료 조성물 | |
KR20160086728A (ko) | 수불용성 스폰지에 자외선 차단기능을 지닌 화장료 조성물이 함침된 화장품 | |
PHADUNGSAKSAWASDI et al. | Contact sensitizing UV filters in sunscreen products in Thailand | |
KR20210051025A (ko) | 자외선 차단용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20160905 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20160921 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160926 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161226 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20161227 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170213 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170315 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6113871 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |